Todos recently entered into an exclusive option agreement to acquire U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab and Provista's proprietary commercial-stage Videssa® breast cancer blood test.
Todos Medical Announces $4.8 Million in Sales for December 2020, a 50% Month Over Month Increase in Sales from November 2020
published 11.01.2021 14:30
finance
COVID-19
company
Medical
product
tests
50%
$4.8 million
today
U.S
United States
Europe
NEW YORK
COVID-19
Company
Biden
#Coronavirus
#ChiefExecutiveOfficer
#CEO
#UnitedStates
#Virus
Similar Posts

15-minute coronavirus antigen tests to be shipped from China to the UK

This Is What It’s Like To Be Part of A COVID-19 Vaccine Trial

The Latest: Germany's CureVac signs contract for new vaccine

Hospital workers called exhausted as U.S. records highest number of COVID deaths since May

Virus-afflicted 2020 looks like 1918 despite science’s march
There is only a slim chance that the vaccine will stop the COVID pandemic this year

AI and Machine Learning for Healthcare

U.S. sets record for COVID-19 hospitalizations, as country’s first case of new U.K. variant is found in Colorado

Neovasc, Inc. (NVCN) CEO Fred Colen on Q2 2020 Results - Earnings Call Transcript

INmune Bio Inc. (INMB) CEO RJ Tesi on Q2 2020 Results - Earnings Call Transcript
